Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy - Trial NCT06287177
Access comprehensive clinical trial information for NCT06287177 through Pure Global AI's free database. This phase not specified trial is sponsored by Federico II University and is currently Recruiting. The study focuses on Hypercholesterolemia. Target enrollment is 1000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Federico II University
Timeline & Enrollment
N/A
Nov 01, 2022
Nov 01, 2024
Primary Outcome
Description of adherence to treatment with Inclisiran in a real-life Italian population,Description of persistence to treatment with Inclisiran in a real-life Italian population,Description of efficacy of treatment with Inclisiran in a real-life Italian population
Summary
Evaluation of adherence, persistence and efficacy of treatment with Inclisiran in a real-life
 Italian population
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06287177
Non-Device Trial